Vinge represents Ellevio in the acquisition of Markbygden Net Väst AB, a network company that connects to the national grid via Svenska kraftnät's station in Trolltjärn outside Arvidsjaur, from Enercon.

Ellevio is one of Sweden's largest electricity network companies, and through the acquisition, Ellevio strengthens its role as a leading player in the Swedish energy transition and the path towards net-zero emissions by 2045. 

Vinge's team consisted of Peter Sundgren (Energy/M&A) together with Gustav Persson and Ida Appelgren (M&A), Johan Cederblad and Lina Österberg (Permits and Environmental Law), Kristoffer Larson and Hanna Kövamees (Real Estate Law), Fredrika Hjelmberg and Siri Blomberg (IT and GDPR), Mario Saad and Jolene Reimerson (Commercial Agreements), Daniel Wendelsson, Dagne Sabockis, Alva Chambert, and Isabell Åkerblom (FDI), Kristoffer Sällfors (Public Procurement), Carl Johan af Petersens and Andrea Rökaas (Regulatory), Niclas Lindblom (Construction Law), Ian Jonson (IP), Amelia Rihs (Labor Law), August Ahlin (Banking and Finance), Gulestan Ali and Jonna Fransson (Compliance), Caroline Löv (Transaction Support).

Related

Vinge advises Atria Sverige in conjunction with an investment in Cookin Food

Atria Sverige has acquired a 25 per cent stake in the Swedish convenience food company Cookin Food Sweden AB. The transaction has been performed through the acquisition of shares in Bite Delight AB, which owns Cookin Food Sweden AB. Atria holds an option to acquire the remaining shares in Bite Delight AB after 2028.
March 04, 2026

Vinge advises Revivo Group on the acquisition of Solidenergy

Revivo Group, a portfolio company of Helix Kapital, has acquired Solidenergy, a leading provider of surface treatment services in the Norwegian market. The company operates within the energy, offshore and infrastructure sectors and is headquartered in Ågotnes outside Bergen. Solidenergy employs approximately 600 people.
March 03, 2026

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a partially guaranteed rights issue which is expected to provide Oncopeptides with proceeds of approximately SEK 200 million before deduction of transaction costs.
March 03, 2026